Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,048

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Diagnosis, Evaluation, and Treatment of Hyponatremia: Expert Panel Recommendations

Verbalis, Joseph G., Goldsmith, Steven R., Greenberg, Arthur, Korzelius, Cynthia, Schrier, Robert W., Sterns, Richard H., Thompson, Christopher J.·2013·The American Journal of Medicine
DOI 10.1016/j.amjmed.2013.07.006
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2013.07.006

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 203

  1. Upadhyay, 2006, Incidence and prevalence of hyponatremia, Am J Med, 119, S30, 10.1016/j.amjmed.2006.05.005 · DOI · Paper page
  2. Verbalis, 2007, Hyponatremia treatment guidelines 2007: expert panel recommendations, Am J Med, 120, S1, 10.1016/j.amjmed.2007.09.001 · DOI · Paper page
  3. DeVita, 1990, Incidence and etiology of hyponatremia in an intensive care unit, Clin Nephrol, 34, 163
  4. Hawkins, 2003, Age and gender as risk factors for hyponatremia and hypernatremia, Clin Chim Acta, 337, 169, 10.1016/j.cccn.2003.08.001 · DOI · Paper page
  5. Bettari, 2012, Hyponatremia and long-term outcomes in chronic heart failure—an observational study from the Duke Databank for Cardiovascular Diseases, J Card Fail, 18, 74, 10.1016/j.cardfail.2011.09.005 · DOI
  6. Balling, 2011, Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure, Eur J Heart Fail, 13, 968, 10.1093/eurjhf/hfr086 · DOI
  7. Gheorghiade, 2007, Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial, Arch Intern Med, 167, 1998, 10.1001/archinte.167.18.1998 · DOI · Paper page
  8. Gheorghiade, 2007, Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry, Eur Heart J, 28, 980, 10.1093/eurheartj/ehl542 · DOI · Paper page
  9. Angeli, 2006, Hyponatremia in cirrhosis: results of a patient population survey, Hepatology, 44, 1535, 10.1002/hep.21412 · DOI · Paper page
  10. Wald, 2010, Impact of hospital-associated hyponatremia on selected outcomes, Arch Intern Med, 170, 294, 10.1001/archinternmed.2009.513 · DOI · Paper page
  11. Anderson, 1985, Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin, Ann Intern Med, 102, 164, 10.7326/0003-4819-102-2-164 · DOI · Paper page
  12. Miller, 1995, Hyponatremia in a nursing home population, J Am Geriatr Soc, 43, 1410, 10.1111/j.1532-5415.1995.tb06623.x · DOI · Paper page
  13. Bettari, 2012, Significance of hyponatremia in heart failure, Heart Fail Rev, 17, 17, 10.1007/s10741-010-9193-3 · DOI
  14. Baldasseroni, 2011, J Cardiovasc Med (Hagerstown), 12, 723, 10.2459/JCM.0b013e32834ae87e · DOI
  15. Gines, 1993, Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites, Gastroenterology, 105, 229, 10.1016/0016-5085(93)90031-7 · DOI · Paper page
  16. Guevara, 2010, Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration, Liver Int, 30, 1137, 10.1111/j.1478-3231.2010.02293.x · DOI
  17. Gines, 2009, Renal failure in cirrhosis, N Engl J Med, 361, 1279, 10.1056/NEJMra0809139 · DOI · Paper page
  18. Sola, 2012, Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema, J Hepatol, 57, 1199, 10.1016/j.jhep.2012.07.020 · DOI
  19. Ruf, 2005, Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone, Liver Transpl, 11, 336, 10.1002/lt.20329 · DOI · Paper page
  20. Hackworth, 2009, Effect of hyponatraemia on outcomes following orthotopic liver transplantation, Liver Int, 29, 1071, 10.1111/j.1478-3231.2009.01982.x · DOI
  21. Kim, 2008, Hyponatremia and mortality among patients on the liver-transplant waiting list, N Engl J Med, 359, 1018, 10.1056/NEJMoa0801209 · DOI · Paper page
  22. Terzian, 1994, Admission hyponatremia in the elderly: factors influencing prognosis, J Gen Intern Med, 9, 89, 10.1007/BF02600208 · DOI
  23. Bennani, 2003, Incidence, causes and prognostic factors of hyponatremia in intensive care, Rev Med Interne, 24, 224, 10.1016/S0248-8663(02)00811-1 · DOI
  24. Chawla, 2011, Mortality and serum sodium: do patients die from or with hyponatremia?, Clin J Am Soc Nephrol, 6, 960, 10.2215/CJN.10101110 · DOI · Paper page
  25. Leung, 2012, Preoperative hyponatremia and perioperative complications, Arch Intern Med, 172, 1474, 10.1001/archinternmed.2012.3992 · DOI
  26. Renneboog, 2006, Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits, Am J Med, 119, 71, 10.1016/j.amjmed.2005.09.026 · DOI · Paper page
  27. Gankam, 2008, Mild hyponatremia and risk of fracture in the ambulatory elderly, QJM, 101, 583, 10.1093/qjmed/hcn061 · DOI · Paper page
  28. Sandhu, 2009, Hyponatremia associated with large-bone fracture in elderly patients, Int Urol Nephrol, 41, 733, 10.1007/s11255-009-9585-2 · DOI
  29. Kinsella, 2010, Hyponatremia independent of osteoporosis is associated with fracture occurrence, Clin J Am Soc Nephrol, 5, 275, 10.2215/CJN.06120809 · DOI · Paper page
  30. Hoorn, 2011, Mild hyponatremia as a risk factor for fractures: the Rotterdam Study, J Bone Miner Res, 26, 1822, 10.1002/jbmr.380 · DOI · Paper page
  31. Verbalis, 2010, Hyponatremia-induced osteoporosis, J Bone Miner Res, 25, 554, 10.1359/jbmr.090827 · DOI · Paper page
  32. Boscoe, 2006, Cost of illness of hyponatremia in the United States, Cost Eff Resour Alloc, 4, 10, 10.1186/1478-7547-4-10 · DOI
  33. Deitelzweig, 2013, Health care utilization, costs, and readmission rates associated with hyponatremia, Hosp Pract (1995), 41, 89, 10.3810/hp.2013.02.1014 · doi:10.3810/hp.2013.02.1014
  34. Amin, 2013, Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US, J Med Econ, 16, 415
  35. Deitelzweig, 2013, Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis, Adv Ther, 30, 71, 10.1007/s12325-012-0073-1 · DOI
  36. Williams, 2012, Hyponatremia with intracranial malignant tumor resection in children, J Neurosurg Pediatr, 9, 524, 10.3171/2012.1.PEDS11465 · doi:10.3171/2012.1.peds11465
  37. Turgutalp, 2013, Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey, Int Urol Nephrol, 45, 265, 10.1007/s11255-012-0307-9 · doi:10.1007/s11255-012-0307-9
  38. Konstam, 2007, Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial, JAMA, 297, 1319, 10.1001/jama.297.12.1319 · DOI · Paper page
  39. Dasta, 2012, Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials, Hosp Pract (1995), 40, 7, 10.3810/hp.2012.02.942 · DOI
  40. Chiong, 2012, Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial, J Med Econ, 15, 276
  41. Robertson, 2006, Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis, Am J Med, 119, S36, 10.1016/j.amjmed.2006.05.006 · DOI
  42. Schrier, 2006, Water and sodium retention in edematous disorders: role of vasopressin and aldosterone, Am J Med, 119, S47, 10.1016/j.amjmed.2006.05.007 · DOI
  43. Weisberg, 1989, Pseudohyponatremia: a reappraisal [Review], Am J Med, 86, 315, 10.1016/0002-9343(89)90302-1 · doi:10.1016/0002-9343(89)90302-1
  44. Hillier, 1999, Hyponatremia: evaluating the correction factor for hyperglycemia, Am J Med, 106, 399, 10.1016/S0002-9343(99)00055-8 · DOI · Paper page
  45. Turchin, 2003, Clinical problem-solving. Mind the gap, N Engl J Med, 349, 1465, 10.1056/NEJMcps031078 · doi:10.1056/nejmcps031078
  46. Huda, 2006, Investigation and management of severe hyponatraemia in a hospital setting, Postgrad Med J, 82, 216, 10.1136/pmj.2005.036947 · DOI
  47. Fenske, 2010, Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study, Am J Med, 123, 652, 10.1016/j.amjmed.2010.01.013 · DOI
  48. Chung, 1987, Clinical assessment of extracellular fluid volume in hyponatremia, Am J Med, 83, 905, 10.1016/0002-9343(87)90649-8 · DOI · Paper page
  49. Schrier, 2006, Body water homeostasis: clinical disorders of urinary dilution and concentration, J Am Soc Nephrol, 17, 1820, 10.1681/ASN.2006030240 · DOI
  50. Fenske, 2008, Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics, J Clin Endocrinol Metab, 93, 2991, 10.1210/jc.2008-0330 · DOI
  51. Hato, 2010, Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia, Hawaii Med J, 69, 264
  52. Schwartz, 1957, A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone, Am J Med, 23, 529, 10.1016/0002-9343(57)90224-3 · DOI · Paper page
  53. Beck, 1979, Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone, N Engl J Med, 301, 528, 10.1056/NEJM197909063011005 · DOI · Paper page
  54. Hew-Butler, 2008, Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007, Clin J Sport Med, 18, 111, 10.1097/JSM.0b013e318168ff31 · DOI
  55. Kim, 2004, Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel, J Am Soc Nephrol, 15, 2836, 10.1097/01.ASN.0000143476.93376.04 · doi:10.1097/01.asn.0000143476.93376.04
  56. Sonnenblick, 1993, Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients [Review], Chest, 103, 601, 10.1378/chest.103.2.601 · DOI · Paper page
  57. Hix, 2011, Diuretic-associated hyponatremia, Semin Nephrol, 31, 553, 10.1016/j.semnephrol.2011.09.010 · DOI
  58. Chow, 2004, Clinical studies of thiazide-induced hyponatremia, J Natl Med Assoc, 96, 1305
  59. Leung, 2011, Risk of thiazide-induced hyponatremia in patients with hypertension, Am J Med, 124, 1064, 10.1016/j.amjmed.2011.06.031 · DOI
  60. Sharabi, 2002, Diuretic induced hyponatraemia in elderly hypertensive women, J Hum Hypertens, 16, 631, 10.1038/sj.jhh.1001458 · DOI
  61. Chow, 2003, Risk factors for thiazide-induced hyponatraemia, QJM, 96, 911, 10.1093/qjmed/hcg157 · DOI
  62. Rodenburg, 2013, Thiazide-associated hyponatremia: a population-based study, Am J Kidney Dis, 62, 67, 10.1053/j.ajkd.2013.02.365 · DOI
  63. Friedman, 1989, Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis, Ann Intern Med, 110, 24, 10.7326/0003-4819-110-1-24 · DOI
  64. Bitew, 2009, More on renal salt wasting without cerebral disease: response to saline infusion, Clin J Am Soc Nephrol, 4, 309, 10.2215/CJN.02740608 · DOI
  65. Hannon, 2012, Clinical review: disorders of water homeostasis in neurosurgical patients, J Clin Endocrinol Metab, 97, 1423, 10.1210/jc.2011-3201 · DOI
  66. Bartter, 1967, The syndrome of inappropriate secretion of antidiuretic hormone, Am J Med, 42, 790, 10.1016/0002-9343(67)90096-4 · DOI · Paper page
  67. Michelis, 1974, Reset of osmoreceptors in association with normovolemic hyponatremia, Am J Med Sci, 267, 267, 10.1097/00000441-197405000-00002 · doi:10.1097/00000441-197405000-00002
  68. Fenske, 2009, Copeptin in the differential diagnosis of hyponatremia, J Clin Endocrinol Metab, 94, 123, 10.1210/jc.2008-1426 · DOI · Paper page
  69. Feldman, 2005, Nephrogenic syndrome of inappropriate antidiuresis, N Engl J Med, 352, 1884, 10.1056/NEJMoa042743 · DOI · Paper page
  70. Decaux, 2007, Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree, J Am Soc Nephrol, 18, 606, 10.1681/ASN.2006090987 · DOI
  71. Zerbe, 1980, Vasopressin function in the syndrome of inappropriate antidiuresis, Annu Rev Med, 31, 315, 10.1146/annurev.me.31.020180.001531 · DOI · Paper page
  72. Ikkos, 1955, Hypophysectomy in man: effect on water excretion during the first two postoperative months, J Clin Endocrinol Metab, 15, 553, 10.1210/jcem-15-5-553 · doi:10.1210/jcem-15-5-553
  73. Diederich, 2003, Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases, Eur J Endocrinol, 148, 609, 10.1530/eje.0.1480609 · DOI
  74. Oelkers, 1989, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism, N Engl J Med, 321, 492, 10.1056/NEJM198908243210802 · DOI · Paper page
  75. Ishikawa, 1982, Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats, Kidney Int, 22, 587, 10.1038/ki.1982.216 · DOI
  76. Hanna, 1997, Hyponatraemia, hypothyroidism, and role of arginine-vasopressin, Lancet, 350, 755, 10.1016/S0140-6736(05)62563-9 · DOI
  77. Chinitz, 1965, The association of primary hypothyroidism and inappropriate secretion of the antidiuretic hormone, Arch Intern Med, 116, 871, 10.1001/archinte.1965.03870060069014 · doi:10.1001/archinte.1965.03870060069014
  78. Derubertis, 1971, Impaired water excretion in myxedema, Am J Med, 51, 41, 10.1016/0002-9343(71)90322-6 · DOI
  79. Irving, 1991, Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia, J Appl Physiol, 70, 342, 10.1152/jappl.1991.70.1.342 · DOI
  80. Speedy, 1999, Hyponatremia in ultradistance triathletes, Med Sci Sports Exerc, 31, 809, 10.1097/00005768-199906000-00008 · DOI · Paper page
  81. Noakes, 2003, Fluid replacement during marathon running, Clin J Sport Med, 13, 309, 10.1097/00042752-200309000-00007 · DOI · Paper page
  82. Hew-Butler, 2005, Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005, Clin J Sport Med, 15, 208, 10.1097/01.jsm.0000174702.23983.41 · DOI
  83. Demanet, 1971, Coma due to water intoxication in beer drinkers, Lancet, 2, 1115, 10.1016/S0140-6736(71)91271-2 · doi:10.1016/s0140-6736(71)91271-2
  84. Thaler, 1998, "Beer potomania" in non-beer drinkers: effect of low dietary solute intake, Am J Kidney Dis, 31, 1028, 10.1053/ajkd.1998.v31.pm9631849 · DOI
  85. Barlow, 1959, Compulsive water drinking, Q J Med, 28, 235
  86. Vieweg, 1988, Diurnal variation in water homeostasis among schizophrenic patients subject to water intoxication, Schizophrenia Res, 1, 351, 10.1016/0920-9964(88)90048-5 · DOI
  87. de Leon, 1994, Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature, Bio Psychiatry, 35, 408, 10.1016/0006-3223(94)90008-6 · DOI · Paper page
  88. Stuart, 1980, Disordered control of thirst in hypothalamic-pituitary sarcoidosis, N Engl J Med, 303, 1078, 10.1056/NEJM198011063031902 · DOI
  89. Noakes, 2001, Peak rates of diuresis in healthy humans during oral fluid overload, S Afr Med J, 91, 852
  90. Cheng, 1990, Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction, Am J Med, 88, 561, 10.1016/0002-9343(90)90518-I · DOI
  91. Goldman, 1988, Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia, N Engl J Med, 318, 397, 10.1056/NEJM198802183180702 · DOI · Paper page
  92. Zucker, 1979, Renal effects of left atrial distension in dogs with chronic congestive heart failure, Am J Physiol, 236, H554
  93. Zucker, 1985, Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload, Cardiovasc Res, 19, 411, 10.1093/cvr/19.7.411 · doi:10.1093/cvr/19.7.411
  94. Abraham, 1998, Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure, J Card Fail, 4, 37, 10.1016/S1071-9164(98)90506-1 · doi:10.1016/s1071-9164(98)90506-1
  95. Berl, 1974, Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol, J Clin Invest, 53, 857, 10.1172/JCI107626 · doi:10.1172/jci107626
  96. Sklar, 1983, Central nervous system mediators of vasopressin release, Physiol Rev, 63, 1243, 10.1152/physrev.1983.63.4.1243 · DOI
  97. Szatalowicz, 1981, Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure, N Engl J Med, 305, 263, 10.1056/NEJM198107303050506 · DOI · Paper page
  98. Schrier, 1988, Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1), N Engl J Med, 319, 1065, 10.1056/NEJM198810203191606 · DOI · Paper page
  99. Schrier, 1988, Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2), N Engl J Med, 319, 1127, 10.1056/NEJM198810273191705 · DOI · Paper page
  100. Myers, 1975, Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat, Circ Res, 37, 101, 10.1161/01.RES.37.1.101 · DOI · Paper page
  101. Gines, 1998, Hyponatremia in cirrhosis: from pathogenesis to treatment, Hepatology, 28, 851, 10.1002/hep.510280337 · DOI · Paper page
  102. Schrier, 1988, Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis, Hepatology, 8, 1151, 10.1002/hep.1840080532 · DOI · Paper page
  103. Martin, 1998, Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis, N Engl J Med, 339, 533, 10.1056/NEJM199808203390807 · DOI · Paper page
  104. Schrier, 1990, Body fluid volume regulation in health and disease: a unifying hypothesis, Ann Intern Med, 113, 155, 10.7326/0003-4819-113-2-155 · DOI · Paper page
  105. Bichet, 1982, Role of vasopressin in abnormal water excretion in cirrhotic patients, Ann Intern Med, 96, 413, 10.7326/0003-4819-96-4-413 · DOI · Paper page
  106. Kovesdy, 2012, Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure, Circulation, 125, 677, 10.1161/CIRCULATIONAHA.111.065391 · DOI · Paper page
  107. Waikar, 2011, Mortality associated with low serum sodium concentration in maintenance hemodialysis, Am J Med, 124, 77, 10.1016/j.amjmed.2010.07.029 · DOI
  108. McManus, 1995, Regulation of cell volume in health and disease, N Engl J Med, 333, 1260, 10.1056/NEJM199511093331906 · DOI · Paper page
  109. Pasantes-Morales, 2006, Mechanisms of cell volume regulation in hypo-osmolality, Am J Med, 119, S4, 10.1016/j.amjmed.2006.05.002 · DOI
  110. Sjoblom, 1997, Fatal hyponatraemic brain oedema due to common gastroenteritis with accidental water intoxication, Intensive Care Med, 23, 348, 10.1007/s001340050340 · doi:10.1007/s001340050340
  111. Verbalis, 2010, Brain volume regulation in response to changes in osmolality, Neuroscience, 168, 862, 10.1016/j.neuroscience.2010.03.042 · DOI
  112. Sterns, 1987, Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases, Ann Intern Med, 107, 656, 10.7326/0003-4819-107-5-656 · DOI · Paper page
  113. Helwig, 1938, Water intoxication. Moribund patient cured by administration of hypertonic salt solution, JAMA, 110, 644, 10.1001/jama.1938.62790090004008c · DOI
  114. Battison, 2005, Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury, Crit Care Med, 33, 196, 10.1097/01.CCM.0000150269.65485.A6 · DOI · Paper page
  115. Sterns, 1986, Osmotic demyelination syndrome following correction of hyponatremia, N Engl J Med, 314, 1535, 10.1056/NEJM198606123142402 · DOI · Paper page
  116. Sterns, 1994, Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective, J Am Soc Nephrol, 4, 1522, 10.1681/ASN.V481522 · doi:10.1681/asn.v481522
  117. Odier, 2010, Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis, J Neurol, 257, 1176
  118. Soupart, 1996, Brain myelinolysis following hypernatremia in rats, J Neuropathol Exp Neurol, 55, 106, 10.1097/00005072-199601000-00011 · doi:10.1097/00005072-199601000-00011
  119. Brunner, 1990, Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonance imaging study, Ann Neurol, 27, 61, 10.1002/ana.410270110 · doi:10.1002/ana.410270110
  120. Baker, 2000, Blood-brain barrier disruption and complement activation in the brain following rapid correction of chronic hyponatremia, Exp Neurol, 165, 221, 10.1006/exnr.2000.7474 · DOI
  121. Lien, 1995, Role of organic osmolytes in myelinolysis. a topographic study in rats after rapid correction of hyponatremia, J Clin Invest, 95, 1579, 10.1172/JCI117831 · doi:10.1172/jci117831
  122. Soupart, 2002, Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia, J Am Soc Nephrol, 13, 1433, 10.1097/01.ASN.0000017903.77985.CD · doi:10.1097/01.asn.0000017903.77985.cd
  123. Sterns, 2006, Brain volume regulation in response to hypo-osmolality and its correction, Am J Med, 119, S12, 10.1016/j.amjmed.2006.05.003 · DOI
  124. Adrogue, 2000, Hyponatremia, N Engl J Med, 342, 1581, 10.1056/NEJM200005253422107 · DOI · Paper page
  125. Sterns, 2010, Treatment of hyponatremia, Curr Opin Nephrol Hypertens, 19, 493, 10.1097/MNH.0b013e32833bfa64 · DOI
  126. Sterns, 2009, The treatment of hyponatremia, Semin Nephrol, 29, 282, 10.1016/j.semnephrol.2009.03.002 · DOI · Paper page
  127. Arieff, 1986, Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women, N Engl J Med, 314, 1529, 10.1056/NEJM198606123142401 · DOI · Paper page
  128. Ayus, 2000, Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners, Ann Intern Med, 132, 711, 10.7326/0003-4819-132-9-200005020-00005 · DOI · Paper page
  129. Ayus, 1995, Pulmonary complications of hyponatremic encephalopathy. noncardiogenic pulmonary edema and hypercapnic respiratory failure [see comments], Chest, 107, 517, 10.1378/chest.107.2.517 · DOI
  130. Koenig, 2008, Reversal of transtentorial herniation with hypertonic saline, Neurology, 70, 1023, 10.1212/01.wnl.0000304042.05557.60 · DOI · Paper page
  131. Moritz, 2010, 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy, Metab Brain Dis, 25, 91, 10.1007/s11011-010-9173-2 · doi:10.1007/s11011-010-9173-2
  132. Rogers, 2011, An intervention study of oral versus intravenous hypertonic saline administration in ultramarathon runners with exercise-associated hyponatremia: a preliminary randomized trial, Clin J Sport Med, 21, 200, 10.1097/JSM.0b013e31821a6450 · DOI
  133. Ellis, 1995, Severe hyponatraemia: complications and treatment, QJM, 88, 905
  134. Tanneau, 1994, High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients, J Clin Psychiatry, 55, 349
  135. Vu, 2009, Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes, Hosp Pract (1995), 37, 128, 10.3810/hp.2009.12.266 · doi:10.3810/hp.2009.12.266
  136. Cluitmans, 1990, Management of severe hyponatremia: rapid or slow correction? [Review], Am J Med, 88, 161, 10.1016/0002-9343(90)90467-R · DOI
  137. Adrogue, 2012, The challenge of hyponatremia, J Am Soc Nephrol, 23, 1140, 10.1681/ASN.2012020128 · DOI
  138. Moritz, 2003, The pathophysiology and treatment of hyponatraemic encephalopathy: an update, Nephrol Dial Transplant, 18, 2486, 10.1093/ndt/gfg394 · DOI
  139. Ayus, 1987, Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study, N Engl J Med, 317, 1190, 10.1056/NEJM198711053171905 · DOI · Paper page
  140. Ayus, 1985, Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis, Am J Med, 78, 897, 10.1016/0002-9343(85)90209-8 · DOI
  141. Mount, 2009, The brain in hyponatremia: both culprit and victim, Semin Nephrol, 29, 196, 10.1016/j.semnephrol.2009.03.021 · DOI
  142. Karp, 1993, Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia, Medicine, 72, 359, 10.1097/00005792-199311000-00001 · doi:10.1097/00005792-199311000-00001
  143. Nzerue, 2003, Predictors of outcome in hospitalized patients with severe hyponatremia, J Natl Med Assoc, 95, 335
  144. Ayus, 1999, Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality [see comments], JAMA, 281, 2299, 10.1001/jama.281.24.2299 · DOI
  145. Arampatzis, 2012, Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission, Am J Med, 125, 1125.e1, 10.1016/j.amjmed.2012.04.041 · DOI
  146. Perianayagam, 2008, DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia, Clin J Am Soc Nephrol, 3, 331, 10.2215/CJN.03190807 · doi:10.2215/cjn.03190807
  147. Mohmand, 2007, Hypertonic saline for hyponatremia: risk of inadvertent overcorrection, Clin J Am Soc Nephrol, 2, 1110, 10.2215/CJN.00910207 · doi:10.2215/cjn.00910207
  148. Sterns, 2010, Treating profound hyponatremia: a strategy for controlled correction, Am J Kidney Dis, 56, 774, 10.1053/j.ajkd.2010.04.020 · DOI
  149. Sood, 2013, Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia, Am J Kidney Dis, 61, 571, 10.1053/j.ajkd.2012.11.032 · doi:10.1053/j.ajkd.2012.11.032
  150. Gankam, 2009, Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats, Kidney Int, 76, 614, 10.1038/ki.2009.254 · doi:10.1038/ki.2009.254
  151. Sugimura, 2005, Protective effect of dexamethasone on osmotic-induced demyelination in rats, Exp Neurol, 192, 178, 10.1016/j.expneurol.2004.10.018 · doi:10.1016/j.expneurol.2004.10.018
  152. Schrier, 1985, Treatment of hyponatremia. [Review], N Engl J Med, 312, 1121, 10.1056/NEJM198504253121709 · DOI
  153. Thibonnier, 1998, Molecular pharmacology of human vasopressin receptors, Adv Exp Med Biol, 449, 251, 10.1007/978-1-4615-4871-3_34 · DOI
  154. Knepper, 1997, Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin, Am J Physiol, 272, F3
  155. Ohnishi, 1993, Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men, J Clin Invest, 92, 2653, 10.1172/JCI116881 · DOI
  156. Hauptman, 2013, Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan, J Card Fail, 19, 390, 10.1016/j.cardfail.2013.04.001 · DOI
  157. Zeltser, 2007, Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia, Am J Nephrol, 27, 447, 10.1159/000106456 · DOI
  158. Torres, 2012, Tolvaptan in patients with autosomal dominant polycystic kidney disease, N Engl J Med, 367, 2407, 10.1056/NEJMoa1205511 · DOI · Paper page
  159. Berl, 2010, Oral tolvaptan is safe and effective in chronic hyponatremia, J Am Soc Nephrol, 21, 705, 10.1681/ASN.2009080857 · DOI · Paper page
  160. Abbasoglu, 1998, Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis, Clin Transplant, 12, 263, 10.1111/j.1399-0012.1998.tb01102.x · doi:10.1111/j.1399-0012.1998.tb01102.x
  161. Fichman, 1971, Diuretic-induced hyponatremia, Ann Intern Med, 75, 853, 10.7326/0003-4819-75-6-853 · DOI · Paper page
  162. Berl, 2010, A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion, Am J Kidney Dis, 55, 742, 10.1053/j.ajkd.2009.12.024 · DOI
  163. Damaraju, 1997, Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis, Neurosurgery, 40, 312, 10.1097/00006123-199702000-00015 · doi:10.1097/00006123-199702000-00015
  164. Hasan, 1990, Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage, Ann Neurol, 27, 106, 10.1002/ana.410270118 · DOI
  165. Wijdicks, 1985, Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?, Ann Neurol, 17, 137, 10.1002/ana.410170206 · DOI · Paper page
  166. Rahman, 2009, Hyponatremia in neurosurgical patients: clinical guidelines development, Neurosurgery, 65, 925, 10.1227/01.NEU.0000358954.62182.B3 · DOI
  167. Hasan, 1989, Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage, Stroke, 20, 1511, 10.1161/01.STR.20.11.1511 · doi:10.1161/01.str.20.11.1511
  168. Ellison, 2007, Clinical practice. The syndrome of inappropriate antidiuresis, N Engl J Med, 356, 2064, 10.1056/NEJMcp066837 · DOI · Paper page
  169. List, 1986, The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer, J Clin Oncol, 4, 1191, 10.1200/JCO.1986.4.8.1191 · doi:10.1200/jco.1986.4.8.1191
  170. Cherrill, 1975, Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion, Ann Intern Med, 83, 654, 10.7326/0003-4819-83-5-654 · DOI
  171. Dousa, 1974, Effect of demethylchlorotetracycline on cellular action of antidiuretic hormone in vitro, Kidney Int, 5, 279, 10.1038/ki.1974.37 · doi:10.1038/ki.1974.37
  172. Miller, 1980, Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients, JAMA, 243, 2513, 10.1001/jama.1980.03300500039026 · DOI
  173. Verbalis, 1988, Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats, Metabolism, 37, 46, 10.1016/0026-0495(88)90028-5 · doi:10.1016/0026-0495(88)90028-5
  174. Coussement, 2012, Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients, Am J Nephrol, 35, 265, 10.1159/000336716 · doi:10.1159/000336716
  175. Decaux, 2010, Treatment of euvolemic hyponatremia in the intensive care unit by urea, Crit Care, 14, R184, 10.1186/cc9292 · DOI
  176. Chehade, 2012, Inappropriate antidiuretic hormone secretion: long-term successful urea treatment, Acta Paediatr, 101, e39, 10.1111/j.1651-2227.2011.02382.x · DOI
  177. Levtchenko, 2010, Nephrogenic syndrome of inappropriate antidiuresis, Nephrol Dial Transplant, 25, 2839, 10.1093/ndt/gfq324 · DOI
  178. Soupart, 2012, Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH, Clin J Am Soc Nephrol, 7, 742, 10.2215/CJN.06990711 · DOI
  179. Robertson, 1982, Neurogenic disorders of osmoregulation, Am J Med, 72, 339, 10.1016/0002-9343(82)90825-7 · DOI · Paper page
  180. Verbalis, 2008, Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study, Clin Endocrinol (Oxf), 69, 159, 10.1111/j.1365-2265.2007.03149.x · DOI
  181. Annane, 2009, Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia, Am J Med Sci, 337, 28, 10.1097/MAJ.0b013e31817b8148 · DOI
  182. Naidech, 2010, Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients, Neurocrit Care, 13, 57, 10.1007/s12028-010-9379-5 · DOI
  183. Verbalis, 2011, Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion, Eur J Endocrinol, 164, 725, 10.1530/EJE-10-1078 · DOI
  184. Thompson, 1989, Effect of blood glucose concentration on osmoregulation in diabetes mellitus, Am J Physiol, 256, R597
  185. Huang, 2006, Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children, J Pediatr, 148, 128, 10.1016/j.jpeds.2005.08.031 · doi:10.1016/j.jpeds.2005.08.031
  186. Kawai, 2002, Risperidone failed to improve polydipsia-hyponatremia of the schizophrenic patients, Psychiatry Clin Neurosci, 56, 107, 10.1046/j.1440-1819.2002.00937.x · DOI
  187. Francis, 1985, Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis, Ann Intern Med, 103, 1, 10.7326/0003-4819-103-1-1 · DOI · Paper page
  188. Decaux, 2006, Is asymptomatic hyponatremia really asymptomatic?, Am J Med, 119, S79, 10.1016/j.amjmed.2006.05.013 · DOI
  189. Licata, 2003, Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects, Am Heart J, 145, 459, 10.1067/mhj.2003.166 · DOI · Paper page
  190. Goldsmith, 2006, Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure, Cleve Clin J Med, 73, S20, 10.3949/ccjm.73.Suppl_2.S20 · DOI
  191. Ghali, 2012, The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study, Eur J Heart Fail, 14, 642, 10.1093/eurjhf/hfs051 · doi:10.1093/eurjhf/hfs051
  192. Goldsmith, 2010, Congestion as a therapeutic target in acute heart failure syndromes, Prog Cardiovasc Dis, 52, 383, 10.1016/j.pcad.2009.11.005 · DOI
  193. Testani, 2010, Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival, Circulation, 122, 265, 10.1161/CIRCULATIONAHA.109.933275 · DOI · Paper page
  194. Rossi, 2007, Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial, Acute Card Care, 9, 82, 10.1080/17482940701210179 · doi:10.1080/17482940701210179
  195. Tamargo, 2011, Novel therapeutic targets for the treatment of heart failure, Nat Rev Drug Discov, 10, 536, 10.1038/nrd3431 · DOI
  196. Ambrosy, 2011, Tolvaptan for the treatment of heart failure: a review of the literature, Expert Opin Pharmacother, 12, 961, 10.1517/14656566.2011.567267 · DOI
  197. Gheorghiade, 2004, Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial, JAMA, 291, 1963, 10.1001/jama.291.16.1963 · DOI · Paper page
  198. Goldsmith, 2005, Vasopressin antagonism in heart failure, J Am Coll Cardiol, 46, 1785, 10.1016/j.jacc.2005.02.095 · DOI
  199. Singh, 2005, Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction?, J Fam Pract, 54, 370
  200. Goldsmith, 2011, Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure, J Card Fail, 17, 982, 10.1016/j.cardfail.2011.08.012 · doi:10.1016/j.cardfail.2011.08.012

200 of 203 shown

Cited by

See all 1,048

Metadata

Authors
Verbalis, J. G., Goldsmith, S. R., Greenberg, A., Korzelius, C., Schrier, R. W., Sterns, R. H., & Thompson, C. J.
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2013-10
Volume
126
Issue
10
Pages
S1-S42
ISSN
0002-9343
DOI
10.1016/j.amjmed.2013.07.006
Cited by
1,048
References
7
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
Otsuka America Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.